Canadian pancreatic cancer specialist expects to open clinical trials on pill that doubled survival time

TORONTO — The head of pancreatic cancer at Princess Margaret Cancer Centre says she hopes clinical trials for a pill that could double survival time will soon be open to Canadian patients.

Medical oncologist Dr.

Jennifer Knox independently reviewed a U.S.-led study of the experimental drug daraxonrasib and calls the results “amazing.” The randomized Phase […] ...